Profil
Meredith Fisher is the founder of Violet Therapeutics, Inc. (founded in 2022) where she holds the title of Co-founding CEO & Director.
She is currently working as a Director at Nocion Therapeutics, Inc., Firecyte Therapeutics, Inc., and Takeda Digital Ventures.
Additionally, she is a Partner at Mass General Brigham Ventures LLC since 2016.
Previously, she served as the Chief Executive Officer & Director at Mediar Therapeutics, Inc. from 2019 to 2023.
She also worked as a Director & Private Investments at Bracebridge Capital LLC from 2013 to 2015 and as a Senior Director-Technology & Business Development at Enlight Biosciences LLC from 2011 to 2012.
Prior to that, she held the position of Principal at Anadys Pharmaceuticals, Inc. and Idenix Pharmaceuticals LLC.
Dr. Fisher holds a doctorate degree from Harvard University, an undergraduate degree from Mount Holyoke College, and an MBA from the Massachusetts Institute of Technology.
Postes actifs de Meredith Fisher
| Sociétés | Poste | Début |
|---|---|---|
Mass General Brigham Ventures LLC
Mass General Brigham Ventures LLC Investment ManagersFinance Mass General Brigham Ventures invests in companies located in the United States. The firm targets companies operating in the fields of drugs, devices, diagnostics, and digital health. It provides financing to seed and early stage capital requirements. It also makes co-investments. | Private Equity Investor | 01/01/2016 |
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops small molecules for nociceptors | Directeur/Membre du Conseil | - |
Firecyte Therapeutics, Inc.
Firecyte Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel treatment strategies for microglia and neuroinflammation | Directeur/Membre du Conseil | - |
Violet Therapeutics
Violet Therapeutics Medical/Nursing ServicesHealth Services Operates as a healthcare company | Fondateur | 01/01/2022 |
Takeda Digital Ventures
Takeda Digital Ventures Investment ManagersFinance Takeda Digital Ventures invests in companies located across the globe primarily in North America and Europe. The firm focuses on the digital health care sector. It provides financing for seed and early stage capital requirements. | Directeur/Membre du Conseil | - |
Anciens postes connus de Meredith Fisher
| Sociétés | Poste | Fin |
|---|---|---|
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Directeur Général | - |
Bracebridge Capital LLC
Bracebridge Capital LLC Investment ManagersFinance Bracebridge seeks to achieve absolute returns primarily by seeking to exploit pricing inefficiencies in financial markets throughout the world. They may employ a variety of strategies in pursuit of this objective. The firm invests and trades primarily in fixed income securities and in the derivatives relating to those securities, but they also seek opportunities in other financial and currency markets. | Private Equity Investor | 31/12/2015 |
Enlight Biosciences LLC
Enlight Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops research tools for drug discovery and development | Directeur Technique/Scientifique/R&D | 31/12/2012 |
| IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 31/12/2002 |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Meredith Fisher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Bracebridge Capital LLC
Bracebridge Capital LLC Investment ManagersFinance Bracebridge seeks to achieve absolute returns primarily by seeking to exploit pricing inefficiencies in financial markets throughout the world. They may employ a variety of strategies in pursuit of this objective. The firm invests and trades primarily in fixed income securities and in the derivatives relating to those securities, but they also seek opportunities in other financial and currency markets. | Finance |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Mount Holyoke College
Mount Holyoke College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mass General Brigham Ventures LLC
Mass General Brigham Ventures LLC Investment ManagersFinance Mass General Brigham Ventures invests in companies located in the United States. The firm targets companies operating in the fields of drugs, devices, diagnostics, and digital health. It provides financing to seed and early stage capital requirements. It also makes co-investments. | Finance |
Enlight Biosciences LLC
Enlight Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops research tools for drug discovery and development | Health Technology |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Health Technology |
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops small molecules for nociceptors | Health Technology |
Takeda Digital Ventures
Takeda Digital Ventures Investment ManagersFinance Takeda Digital Ventures invests in companies located across the globe primarily in North America and Europe. The firm focuses on the digital health care sector. It provides financing for seed and early stage capital requirements. | Finance |
Firecyte Therapeutics, Inc.
Firecyte Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel treatment strategies for microglia and neuroinflammation | Commercial Services |
Violet Therapeutics
Violet Therapeutics Medical/Nursing ServicesHealth Services Operates as a healthcare company | Health Services |
















